Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
British Journal of Cancer|March 1, 1992
Patterns of survival in patients with advanced Hodgkin's disease (HD) treated in a single centre over 20 yearsA M Oza, T S Ganesan, M Dorreen, et al.
Gynecologic Oncology|April 22, 2015
A phase 2 study of cediranib in recurrent or persistent ovarian, peritoneal or fallopian tube cancer: a trial of the Princess Margaret, Chicago and California Phase II ConsortiaH Hirte, S Lheureux, G F Fleming, et al.
European Journal of Cancer (Oxford, England : 1990)|June 30, 2006
Characterisation of the lung toxicity of the cell cycle inhibitor temsirolimusI Duran, L L Siu, A M Oza, et al.
British Journal of Haematology|March 1, 1993
The management of recurrent acute myelogenous leukaemia at a single centre over a fifteen-year periodC L Davis, A Z Rohatiner, J Lim, et al.
Leukemia|January 1, 1992
Short term therapy (STT) for acute myelogenous leukaemia (AML)A Z Rohatiner, R Battista, R Bassan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1993
Patterns of survival in patients with Hodgkin's disease: long follow up in a single centreA M Oza, T S Ganesan, M Leahy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 31, 2011
Temsirolimus in combination with carboplatin and paclitaxel in patients with advanced solid tumors: a NCIC-CTG, phase I, open-label dose-escalation study (IND 179)C Kollmannsberger, H Hirte, L L Siu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 14, 2010
A phase II study of sunitinib in patients with recurrent epithelial ovarian and primary peritoneal carcinoma: an NCIC Clinical Trials Group StudyJ J Biagi, A M Oza, H I Chalchal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2000
Phase I dose-finding and pharmacokinetic study of paclitaxel and carboplatin with oral valspodar in patients with advanced solid tumorsA Patnaik, E Warner, M Michael, et al.
British Journal of Cancer|November 12, 2015
A phase I combination dose-escalation study of eribulin mesylate and gemcitabine in patients with advanced solid tumours: a study of the Princess Margaret ConsortiumS Lheureux, A M Oza, S A Laurie, et al.
Pageof 5